Untoward hematologic responses to the antithyroid compounds
- 31 July 1954
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 17 (1) , 36-40
- https://doi.org/10.1016/0002-9343(54)90141-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- PROGNOSIS OF HYPERTHYROIDISM TREATED BY ANTITHYROID DRUGSJAMA, 1953
- TREATMENT OF THYROTOXICOSIS WITH METHIMAZOLE* (1-METHYL-2-MERCAPTOIMIDAZOLE)The Lancet Healthy Longevity, 1951
- TREATMENT OF HYPERTHYROIDISM WITH 1-METHYL-2-MERCAPTOIMIDAZOLEJAMA, 1950
- l-METHYL-2-MERCAPTOIMIDAZOLE: AN ANTITHYROID COMPOUND HIGHLY ACTIVE IN MAN1Endocrinology, 1949
- The Biology of Antithyroid AgentsPublished by Elsevier ,1947
- THE EFFECT OF THIOURACIL ON THE RESPIRATION OF BONE MARROW AND LEUCOCYTES IN VITROAmerican Journal of Physiology-Legacy Content, 1945
- THE EFFECT OF THIOURACIL ON TISSUE OXIDASEScience, 1945
- The Effect of Thiouracil on the Respiration of Bone Marrow and Leucocytes in VitroScience, 1945
- THIOURACIL. ITS ABSORPTION, DISTRIBUTION, AND EXCRETION 1Journal of Clinical Investigation, 1944
- TREATMENT OF HYPERTHYROIDISM WITH THIOUREA AND THIOURACILJAMA, 1943